Yogaros Gold 75mg/20mg/75mg Capsule is a combination medication containing Aspirin (75mg), Rosuvastatin (20mg), and Clopidogrel (75mg), indicated for the prevention and management of cardiovascular diseases. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase, thereby reducing thromboxane A2 synthesis and preventing platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to atherosclerosis risk reduction. Clopidogrel, another antiplatelet agent, selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor, thereby preventing activation of the glycoprotein IIb/IIIa complex and subsequent platelet aggregation. The combined action of these agents provides comprehensive cardiovascular protection by reducing the risk of thrombotic events such as myocardial infarction, stroke, and peripheral arterial disease in patients with established atherosclerotic disease or high cardiovascular risk. Yogaros Gold is prescribed under medical supervision, with careful consideration of contraindications such as active bleeding, hypersensitivity, or severe hepatic impairment. Regular monitoring of lipid profiles, liver function, and bleeding parameters is recommended to optimize therapeutic outcomes and minimize adverse effects.